CAUSEY CHRISTOPHER sold 38.1% of their position (3K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $1.27M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/2/2025ACC: 0001237334-25-000003
Director
Since Mar 2026
-3K
Net shares
Net seller
$1.27M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
3K acquired · 6K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3K
Price / share
$132.30
Trade value
$396.90K
% of position
61.7%
9/2/2025
4.87K→7.87K
Common Stock
Direct
Shares
−1K
Price / share
$419.63
Trade value
$419.63K
% of position
12.7%
9/2/2025
7.87K→6.87K
Common Stock
Direct
Shares
−1K
Price / share
$430.00
Trade value
$430K
% of position
14.6%
9/2/2025
6.87K→5.87K
Common Stock
Direct
Shares
−1K
Price / share
$420.00
Trade value
$420K
% of position
17.1%
9/2/2025
5.87K→4.87K
Total
Net shares
+0.00
Net value
-$872.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | M · Option Exercise | +3K | $132.30 | $396.90K | 61.7% | 4.87K | 7.87K |
| Common Stock Direct | 9/2/2025 | S · Sale | −1K | $419.63 | $419.63K | 12.7% | 7.87K | 6.87K |
| Common Stock Direct | 9/2/2025 | S · Sale | −1K | $430.00 | $430K | 14.6% | 6.87K | 5.87K |
| Common Stock Direct | 9/2/2025 | S · Sale | −1K | $420.00 | $420K | 17.1% | 5.87K | 4.87K |
| Total | +0.00 | -$872.73K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
3K shares
Shares
−3K
Strike price
132.30
Held after
0.00
Exercisable
—
9/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock3K shares | 9/2/2025 | M · Option Exercise | −3K | 132.30 | — | 0.00 |